Mar 28 |
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
|
Mar 28 |
Recap: Accelerate Diagnostics Q4 Earnings
|
Mar 28 |
Accelerate Diagnostics GAAP EPS of -$0.89 misses by $0.27, revenue of $3M misses by $0.45M
|
Mar 28 |
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|
Mar 7 |
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
|
Jan 31 |
Peering Into Accelerate Diagnostics's Recent Short Interest
|
Jan 19 |
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Jan 19 |
Why Accelerate Diagnostics (AXDX) Stock Is Down 38%
|
Jan 19 |
Accelerate Diagnostics prices $15M public offering and private placement, shares fall
|